LP-12

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
LP-12
LP-12 structure.png
Identifiers
  • 4-(2-diphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC32H39N3O
Molar mass481.684 g·mol−1
3D model (JSmol)
  • C5CCc1ccccc1C5NC(=O)CCCCCN3CCN(CC3)c2ccccc2-c4ccccc4
  • InChI=1S/C32H39N3O/c36-32(33-30-18-11-15-26-14-6-7-16-28(26)30)20-5-2-10-21-34-22-24-35(25-23-34)31-19-9-8-17-29(31)27-12-3-1-4-13-27/h1,3-4,6-9,12-14,16-17,19,30H,2,5,10-11,15,18,20-25H2,(H,33,36) ☒N
  • Key:NMZIDFFHGCRAJV-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

LP-12 is a drug which acts as a potent agonist at the 5HT7 serotonin receptor, with very high selectivity over other tested receptor subtypes such as the serotonin 5-HT1A and 5-HT2A, and the dopamine D2 receptor. It has been used to research the involvement of the 5-HT7 receptor in as yet poorly understood processes such as allodynia and hyperalgesia.[1]

See also[edit]

References[edit]

  1. ^ Godínez-Chaparro B, Barragán-Iglesias P, Castañeda-Corral G, Rocha-González HI, Granados-Soto V (March 2011). "Role of peripheral 5-HT(4), 5-HT(6), and 5-HT(7) receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia". Pain. 152 (3): 687–97. doi:10.1016/j.pain.2010.12.020. PMID 21239110. S2CID 140204185.